OPNT - オピアント・ファ―マシュ―ティカルズ (Opiant Pharmaceuticals Inc.)

OPNTのニュース

   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha
   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha
   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha

calendar